EPISODE · Mar 5, 2025 · 2 MIN
RENOVE Trial Overview 📑
from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC
The RENOVE trial compared reduced-dose versus full-dose DOACs for extended venous thromboembolism VTE treatment in high-risk patients. While the reduced dose cut major bleeding risk by 39% 🚨, it did not meet non-inferiority criteria for preventing VTE recurrence 🔄.
NOW PLAYING
RENOVE Trial Overview 📑
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m